Filing Details
- Accession Number:
- 0001645627-17-000104
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-11 21:26:08
- Reporting Period:
- 2017-08-07
- Filing Date:
- 2017-08-11
- Accepted Time:
- 2017-08-11 21:26:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-07 | 2,000 | $0.03 | 22,199,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-07 | 2,000 | $0.03 | 22,201,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-07 | 2,000 | $0.03 | 22,203,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-07 | 5,000 | $0.03 | 22,208,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-07 | 2,000 | $0.03 | 22,210,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-08 | 2,000 | $0.03 | 22,212,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-08 | 2,000 | $0.03 | 22,214,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-08 | 2,000 | $0.03 | 22,216,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-08 | 2,000 | $0.03 | 22,218,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-08 | 3,000 | $0.03 | 22,221,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-08 | 5,000 | $0.03 | 22,226,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-08 | 3,000 | $0.03 | 22,229,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-08 | 2,000 | $0.03 | 22,231,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-09 | 2,000 | $0.03 | 22,233,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-09 | 2,000 | $0.03 | 22,235,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-09 | 5,000 | $0.03 | 22,240,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-09 | 2,000 | $0.03 | 22,242,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 3,000 | $0.03 | 22,245,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 2,000 | $0.03 | 22,247,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 5,000 | $0.03 | 22,252,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 2,000 | $0.03 | 22,254,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 2,000 | $0.03 | 22,256,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 2,000 | $0.03 | 22,258,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 2,000 | $0.03 | 22,260,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 2,000 | $0.03 | 22,262,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 5,000 | $0.03 | 22,267,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 2,000 | $0.03 | 22,269,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 2,000 | $0.03 | 22,271,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 2,000 | $0.03 | 22,273,389 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-10 | 2,000 | $0.03 | 22,275,389 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
